Antidepressant treatment and neural plasticity

Journal of Child and Adolescent Psychopharmacology

Volumn 10, Issue 4, 2000, Pages 287-294

  El Mallakh, Rif S ^a   Peters, Christopher ^a   Waltrip, Courtney ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AFFECTIVE NEUROSIS; ARTICLE; BRAIN DEVELOPMENT; CHILD; DEPRESSION; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PRENATAL DRUG EXPOSURE; TARDIVE DYSKINESIA;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN CHEMISTRY; HUMANS; NEURONAL PLASTICITY; SEROTONIN;

EID: 0034492733     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2000.10.287     Document Type: Article

References (69)

1. Criteria for the 'soft' bipolar spectrum: Treatment implications
2. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: Pharmacokinetics, tolerability, and efficacy
3. Switch from depression to mania, or from mania to depression: Role of psychotropic drugs
4. Modulation of in vivo neuronal sprouting by serotonin in adult CNS of the snail
5. Risks and implications of interrupting maintenance psychotropic drug therapy
6. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study
7. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei
8. Estimation of the association between desipramine and the risk of sudden death in 5- to 14-year-old children
9. Electrophysiological investigations on the effect of repeated zimeldine administration on serotonergic neurotransmission in the rat
10. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
11. Changing of synaptic density in the primary visual cortex of the rhesus monkey from fetal to adult stage
12. Altered branching of serotonin-containing neurons in Drosophila mutants unable to synthesize serotonin and dopamine
13. Loss of antidepressant efficacy during maintenance therapy: Possible mechanisms and treatments
14. Birth outcomes in pregnant women taking fluoxetine
15. Receptor sensitivity and the mechanism of action of antidepressant treatment
16. The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture
17. Serotonin reuptake inhibitor withdrawal
18. Characterization and development of rotational behavior in Helisoma embryos: Role of endogenous serotonin
19. Neurite branch development of an identified serotonergic neuron from embryonic Helisoma: Evidence for autoregulation by serotonin
20. Antidepressant withdrawal phenomena
21. Sertaraline in the prevention of depression
22. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia
23. Bipolar illness
24. New insights into the course and prognosis of bipolar illness
25. Can long-term antidepressant use be depressogenic?
26. A double-blind randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
27. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression
28. Expression and function of the neurotransmitter serotonin during development of the Helisoma nervous system
29. Novel effects of serotonin on neurite outgrowth in neurons cultured from embryos of Helisoma trivolvis
30. Effect of anticholinergics on tardive dyskinesia, a controlled discontinuation study
31. Newer antidepressants and the discontinuation syndrome
32. Serotonin selectively inhibits growth cone motility and synaptogenesis of specific identified neurons
33. The regulation of neurite outgrowth, growth cone mobility, and electrical synaptogenesis by serotonin
34. Long-term management of depression
35. Design and methodology issues for clinical treatment trials in children and adolescents
36. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness
37. Course of bipolar disorder in eastern India
38. Not all that moves is tardive dyskinesia
39. The course of childhood onset depressive disorders
40. Childhood onset dysthymic disorder: Clinical features and prospective naturalistic outcome
41. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicenter study
42. Long-term treatment of depression
43. Ontogeny of the serotonergic system in the rat: Serotonin as a developmental signal
44. In vivo and in vitro development of serotonergic neurons
45. Antidepressant discontinuation: A review of the literature
46. Dopamine and serotonin inhibition of neurite elongation and different identified neurons
47. Lack of evidence for serotonergic effect on the cellular development of the olfactory bulb in the postnatal rat
48. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment
49. Coadministration of haloperidol and SCH-23390 prevents the increase in "perforated" synapses due to either drug alone
50. The prophylactic efficacy of fluoxetine in unipolar depression
51. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
52. Neurodevelopment of children exposed in utero to antidepressant drugs
53. Reevaluation of the indoleamine hypothesis of depression: Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs
54. Pregnancy outcome following first trimester exposure to fluoxetine (Prozac)
55. Long-term antidepressant treatment decreases spriroperidol-labeled serotonin receptor binding
56. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
57. Synaptic development of the cerebral cortex: Implications for learning, memory, and mental illness
58. Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment
59. Pharmacology of antidepressants-Characteristics of the ideal drug
60. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake
61. Course of depression in adults: Treatment options
62. Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition
63. 1A receptors control neurite branching during development
64. Antidepressant-associated mania: A controlled comparison with spontaneous mania
65. Discontinuation of antidepressant therapy: Emerging complications and their relevance
66. Rapid cycling in manic-depressives induced by tricyclic antidepressants
67. Role of high affinity serotonin receptors in neuronal growth
68. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: A literature review